Clinical Trial Update: Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 study evaluating safety and tolerability of PF-07242813 in healthy participants and in individuals with atopic dermatitis; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PF-07242813

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED | Results posted: 2024-06-03